Predictive Factors for Gram-negative Versus Gram-positive Bloodstream Infections in Children With Cancer

Angeliki-Eleni Sfetsiori1, Dimitrios Doganis2, Anastasios Doudoulakakis3

  • 1Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens.

Insights

Identifying predictive factors for Gram-negative vs. Gram-positive bacteremia in pediatric cancer patients is crucial for effective antibiotic treatment. Girls, hematologic malignancy, and higher CRP levels predict Gram-negative infections, while neutropenic boys with solid tumors and CVCs may face Gram-positive risks.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Bacterial bloodstream infections (BSIs) are a significant concern in pediatric cancer patients.
  • Timely identification of bacteremia type (Gram-negative vs. Gram-positive) is critical for appropriate empiric antibiotic therapy.
  • Predictive factors for bacteremia type can optimize treatment strategies.

Purpose of the Study:

  • To identify demographic, clinical, and laboratory factors predicting the type of bacteremia in children with cancer.
  • To correlate these factors with Gram-negative versus Gram-positive bacterial isolates.
  • To inform empiric antibiotic selection for pediatric cancer patients with BSI.

Main Methods:

  • Retrospective analysis of children with cancer and bacterial bloodstream infections (BSIs) from February 2011 to February 2018.
  • Examination of demographic, clinical, and laboratory data.
  • Correlation of patient characteristics with the type of isolated bacteria (Gram-negative vs. Gram-positive).

Main Results:

  • Gram-negative bacteria were more frequent in girls, patients with prior BSIs, and those with hematologic malignancies.
  • Gram-negative BSIs correlated with lower leukocyte, neutrophil, and platelet counts, and higher C-reactive protein (CRP) levels.
  • Female sex, hematologic malignancy, and elevated CRP were independent risk factors for Gram-negative BSI; neutropenic boys with solid tumors and recent central venous catheter (CVC) placement were at increased risk for Gram-positive BSI.

Conclusions:

  • Gram-negative and Gram-positive BSIs are nearly balanced in pediatric cancer patients.
  • Girls, hematologic malignancies, and higher CRP levels are associated with Gram-negative bacteremia.
  • Neutropenic boys with solid tumors and recent CVC placement may require initial antibiotics targeting Gram-positive bacteria.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
41
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
45
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534